Impact of Treatment With Intramuscular, Injectable, Extended-Release Naltrexone on Counseling and Support Group Participation in Patients With Alcohol Dependence

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of addiction medicine

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/ADM.0b013e3181c82207PMID 21769033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extended-Release Intramuscular Naltrexone

  2012cited by this paper
• Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.

  2008cited by this paper
• What role does measuring medication compliance play in evaluating the efficacy of naltrexone?

  2007cited by this paper
• Efficacy of Extended-Release Naltrexone in Alcohol-Dependent Patients Who Are Abstinent Before Treatment

  2007cited by this paper
• Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

  2006cited by this paper
• Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.

  2006cited by this paper
• Outcome of treatment for alcohol abuse and involvement in alcoholics anonymous among previously untreated problem drinkers

  2006cited by this paper
• The BRENDA Model: Integrating Psychosocial Treatment and Pharmacotherapy for the Treatment of Alcohol Use Disorders

  2006cited by this paper
• Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial

  2005influential reference
• Helping Patients Who Drink Too Much

  2005cited by this paper
• Adoption of naltrexone to treat alcohol dependence.

  2005cited by this paper
• Naltrexone Combined With Either Cognitive Behavioral or Motivational Enhancement Therapy for Alcohol Dependence

  2005influential reference
• Assessing the efficacy of medical treatments for alcohol use disorders

  2004cited by this paper
• A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.

  2003cited by this paper
• Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.

  2003cited by this paper
• Barriers to the use of medications to treat alcoholism.

  2001influential reference
• Beyond the Influence: Understanding and Defeating Alcoholism

  2001cited by this paper
• Combining Medication and Psychosocial Treatments for Addictions: The BRENDA Approach

  2001cited by this paper
• Long-term outcomes of alcohol use disorders: comparing untreated individuals with those in alcoholics anonymous and formal treatment.

  2000cited by this paper
• Improving Naltrexone Response

  2000influential reference
• Alcoholics Anonymous and the use of medications to prevent relapse: an anonymous survey of member attitudes.

  2000influential reference
• Brief Intervention in Primary Care Settings

  1999cited by this paper
• Does Alcoholics Anonymous involvement predict treatment outcome?

  1995cited by this paper
• Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption

  1992cited by this paper
• Zero-inflated Poisson regression, with an application to defects in manufacturing

  1992cited by this paper
• The Use of Ranks to Avoid the Assumption of Normality Implicit in the Analysis of Variance

  1937cited by this paper

• Efficacy of Extended-Release Injectable Naltrexone on Alcohol Use Disorder Treatment: A Systematic Review

  2022cites this paper
• Socio-demographic and clinical factors associated with drop out from walk in-clinic in patients with psychoactive substance use

  2019cites this paper
• Managing Problem Drinking: Screening Tools and Brief Interventions for Primary Care Physicians

  2017cites this paper
• Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence

  2017cites this paper
• A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri.

  2016cites this paper
• Initiation and retention in couples outpatient treatment for parents with drug and alcohol use disorders.

  2016cites this paper
• Technology-Assisted Addiction Treatment for Key Populations

  2014cites this paper
• Intramuscular extended‐release naltrexone: current evidence

  2011cites this paper